Jim Simons Catalyst Biosciences, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.33 - $0.65 $60,620 - $119,404	-183,699 Reduced 23.72%	590,687 $285,000
Q2 2023 Aug 11, 2023	SELL	$0.2 - $0.35 $20,300 - $35,525	-101,500 Reduced 11.59%	774,386 $272,000
Q1 2023 May 12, 2023	SELL	$0.19 - $0.64 $59,109 - $199,104	-311,100 Reduced 26.21%	875,886 $181,000
Q4 2022 Feb 13, 2023	BUY	$0.49 - $0.57 $42,000 - $48,858	85,716 Added 7.78%	1,186,986 $626,000
Q3 2022 Nov 14, 2022	BUY	$0.49 - $1.95 $149,099 - $593,353	304,284 Added 38.18%	1,101,270 $555,000
Q2 2022 Aug 12, 2022	SELL	$0.36 - $1.78 $134,235 - $663,719	-372,876 Reduced 31.87%	796,986 $1.42 Million
Q1 2022 May 13, 2022	SELL	$0.51 - $1.0 $307,043 - $602,046	-602,046 Reduced 33.98%	1,169,862 $772,000
Q4 2021 Feb 11, 2022	BUY	$0.91 - $4.16 $1.58 Million - $7.21 Million	1,732,123 Added 4353.71%	1,771,908 $1.62 Million
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $1.54 Million - $2.12 Million	-408,412 Reduced 91.12%	39,785 $164,000
Q2 2021 Aug 13, 2021	BUY	$4.1 - $5.33 $1.84 Million - $2.39 Million	448,197 New	448,197 $1.94 Million
Q1 2021 May 13, 2021	SELL	$4.93 - $7.15 $717,354 - $1.04 Million	-145,508 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$4.55 - $7.29 $479,993 - $769,043	-105,493 Reduced 42.03%	145,508 $918,000
Q3 2020 Nov 13, 2020	BUY	$4.22 - $6.04 $709,774 - $1.02 Million	168,193 Added 203.11%	251,001 $1.08 Million
Q2 2020 Aug 13, 2020	BUY	$3.76 - $8.01 $148,520 - $316,395	39,500 Added 91.21%	82,808 $486,000
Q1 2020 May 14, 2020	SELL	$3.5 - $8.51 $20,300 - $49,358	-5,800 Reduced 11.81%	43,308 $189,000
Q4 2019 Feb 13, 2020	BUY	$4.52 - $7.91 $221,968 - $388,444	49,108 New	49,108 $334,000
Q3 2019 Nov 13, 2019	SELL	$4.91 - $9.31 $78,599 - $149,034	-16,008 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$7.08 - $10.6 $1.14 Million - $1.7 Million	-160,682 Reduced 90.94%	16,008 $118,000
Q1 2019 May 14, 2019	SELL	$7.67 - $9.96 $171,102 - $222,187	-22,308 Reduced 11.21%	176,690 $1.43 Million
Q4 2018 Feb 13, 2019	BUY	$6.59 - $11.28 $1.31 Million - $2.24 Million	198,998 New	198,998 $1.57 Million

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account